Home >  Blog >  Buzzy® or Pikluc®? Comparing Pain Relief During Children’s Intramuscular Injections

Buzzy® or Pikluc®? Comparing Pain Relief During Children’s Intramuscular Injections

Posted on 29 December 2026
Buzzy® or Pikluc®? Comparing Pain Relief During Children’s Intramuscular Injections
Study Overview
Intramuscular injections can be painful and distressing for children. Devices that combine distraction, vibration or cooling may offer a simple non-pharmacological way to make the experience more comfortable.
This randomised equivalence trial compared Buzzy® applied for 15 seconds, Pikluc®, and Buzzy® applied for 30 seconds in 170 children aged 1-11 years receiving intramuscular injections at two paediatric emergency units in Brazil.

Key Findings
  • For children aged 1-3 years, pain relief was equivalent across all three approaches.
  • This suggests that Pikluc® could be applied immediately and that a shorter 15-second Buzzy® application produced similar pain outcomes to the longer 30-second application in this younger group.
  • For children aged 4-11 years, self-reported pain did not demonstrate equivalence between the approaches.
  • Observer and parent assessments also did not always align with children’s own reports, highlighting the importance of considering the child’s voice when evaluating procedural pain.

Implications
Both Buzzy® and Pikluc® may offer practical options for supporting younger children during intramuscular injections.
The differences seen in older children also reinforce that pain is subjective and that self-reported pain should remain an important part of assessment whenever children are able to communicate their experience.

Read more:https://doi.org/10.1016/j.pmn.2026.03.016

Authors; Jefferson Wildes da Silva Moura; Mari Takashima; Sabrina de Souza; Thiago Lopes Silva; Aline de Souza Bitencourt; Kaili da Silva Medeiros; Henrik Hjelmgren; Luciano Marques Dos Santos; Amanda Ullman; Patrícia Kuerten Rocha

Address

Griffith University
Nathan
Queensland
Australia 4111